
Reccan
Developer of diagnostic tools designed to improve the detection and management of pancreatic cancer. The company applies translational research methodologies grounded in clinical data and national reg...
Valuation
$0
Share Price
N/A
Total Raised
$4.6M
Last Round
N/A